FentaNYL 500 mcg/250 mL - Bupivacaine HCl 0.1% in 0.9% Sodium Chloride 250mL Bag, Injection for E...

FDA Recall #D-0945-2023 — Class II — July 20, 2023

Recall #D-0945-2023 Date: July 20, 2023 Classification: Class II Status: Terminated

Product Description

FentaNYL 500 mcg/250 mL - Bupivacaine HCl 0.1% in 0.9% Sodium Chloride 250mL Bag, Injection for Epidural Use (fentaNYL Concentration - 2 mcg/mL), Rx Only, Single Dose Container, SCA Pharmaceuticals, 755 Rainbow Rd, Windsor, CT 06095, NDC# 70004-0253-40

Reason for Recall

cGMP deviations: due to shipment of rejected units.

Recalling Firm

SCA Pharmaceuticals — Windsor, CT

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

183 bags

Distribution

KY and NJ

Code Information

Lot # 1223047134, Use By: 09/21/2023

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated